期刊文献+

针药并用对帕金森病小鼠纹状体DA、NE和5-羟色胺的影响 被引量:12

Effect of Combined Acupuncture and Medicine on Striatal DA,NE and 5-hydroxytryptamine in a Mouse Model of Parkinson Disease
下载PDF
导出
摘要 目的观察平颤解郁方配合针刺治疗对帕金森病模型小鼠纹状体DA、NE和5-HT等神经递质的影响。方法将成年C_(57)/BL雄性小鼠28只随机分为正常组、模型组、西药组和针药组4组,每组7只。采用高效液相色谱-电化学检测法,测定各组小鼠纹状体DA、NE和5-羟色胺(5-HT)的含量。结果模型组、西药组和针药组小鼠纹状体DA、NE、5-HT含量均显著低于正常组(P<0.01,P<0.05),西药组和针药组小鼠纹状体DA、NE、5-HT含量显著高于模型组(P<0.01,P<0.05)。结论平颤解郁方配合针刺治疗可提高纹状体下降的DA、NE、5-HT水平。 Objective To investigate the effect of tremor and depression-relieving prescription plus acupuncture on striatal neurotransmitters DA, NE and 5-HT in a mouse model of Parkinson disease. Methods Twenty-eight adult male C57/BL mice were randomly allocated to four groups: normal, model, Western drug and combined acupuncture and medicine, 7 mice each. Striatal DA, NE and 5-hydroxytryptamine (5-HT) contents were measured by high efficiency liquid chromatography-electrochemical determination in every group of mice. Results Striatal DA, NE and 5-hydroxytryptamine (5-HT) contents were significantly lower in the model, Western drug and combined acupuncture and medicine groups of mice than in the normal group (P〈0.01,P〈0.05) and significantly higher in the Western drug and combined acupuncture and medicine groups of mice than in the model group (P〈0.01, P〈0.05). Conclusion Tremor and depression-relieving prescription combined with acupuncture can raise low striatal DA, NE and 5-HT levels.
出处 《上海针灸杂志》 2011年第1期56-58,共3页 Shanghai Journal of Acupuncture and Moxibustion
基金 上海市卫生局青年科研项目(2009Y084) 上海中医药大学附属岳阳中西医结合医院科技新星项目 上海市重点学科建设项目(S30304)
关键词 针刺 电针 帕金森病 大鼠 平颤解郁方 针药并用 Acupuncture Electroacupuncture Parkinson disease Mouse Tremor and depression-relieving prescription Combined use of acupuncture and medicine
  • 相关文献

参考文献10

  • 1李仪奎.中药药理试验方法学[M].上海:上海科技出版社,1991,298-353.
  • 2Slaughter JR, Slaughter KA. Prevalence clinical manifestations, etiol- ogy, and treatment of depression in Parkinson's disease[J]. J Neuropsychiatry Clin Neurosci, 2001, 13 (2) : 187-196.
  • 3Philippe R, Miroslava D, Andrew L, et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system[J]. Brain, 2005, 128(6) : 1314-1322.
  • 4Schuurman AG, van den Akker M, Ensinck KTJL, et al. Increased risk of Parkinson's disease after depression: A retrospective cohort study[J]. Neurology, 2002, 58 (10) : 1501-1504.
  • 5Cote L. Depression: impact and management by the patient and family[J]. Neurology, 1999, 52(7 Suppl 3) :S7-9.
  • 6Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabo- lism in the inferior frontal lobe in depressed patients with Parkinson's disease[J].Ann Neurol, 1990,28(1):57-64.
  • 7Dunnett SB, Bjorklund A. Prospects for new restorative and neuropro- tective treatments in Parkinson's disease[J]. Nature, 1999, 399 (6738 Suppl) :A32-39.
  • 8Beal ME Experimental models of Parkinson's disease[J]. Nat Rev Neurosei, 2001, 2 (5) : 325-334.
  • 9Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by l-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-l,2,5,6-tetrahy- dropyridine[J]. Life Sci, 1985, 36 (26) :2503-2508.
  • 10Nicklas WJ, Youngster SK, Kindt MY, et al. MPTP, MPP + and mitochondrial function[J]. Life Sci, 1987, 40 (8) : 721-729.

共引文献34

同被引文献196

引证文献12

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部